摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,6-二(2-哌啶-1-基乙氧基)氧杂蒽-9-酮 | 38020-47-2

中文名称
3,6-二(2-哌啶-1-基乙氧基)氧杂蒽-9-酮
中文别名
——
英文名称
3,6-Bis-(2-piperidinoethoxy)-xanthon
英文别名
3,6-bis-(2-piperidin-1-yl-ethoxy)-xanthen-9-one;9H-Xanthen-9-one, 3,6-bis(2-(piperidino)ethoxy)-;3,6-bis(2-piperidin-1-ylethoxy)xanthen-9-one
3,6-二(2-哌啶-1-基乙氧基)氧杂蒽-9-酮化学式
CAS
38020-47-2
化学式
C27H34N2O4
mdl
——
分子量
450.578
InChiKey
ONSDKIXVFSBVLU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    33
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    51.2
  • 氢给体数:
    0
  • 氢受体数:
    6

安全信息

  • 海关编码:
    2934999090

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    3,6-二羟基-9H-氧杂蒽-9-酮 以21%的产率得到
    参考文献:
    名称:
    CARR A. A.; GRUNWELL J. F.; SILL A. D.; MEYER D. R.; SWEET F. W.; SCHEVE +, J. MED. CHEM. , 1976, 19, NO 9, 1142-1148
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Amino-substituted tricyclic derivatives and methods of use
    申请人:Schrimpf R. Michael
    公开号:US20050171079A1
    公开(公告)日:2005-08-04
    Compounds of formula (I) wherein A and B are amine-substituted sidechains, Y 1 and Y 2 form various tricyclic cores, and R x is an optional substituent. Compounds and compositions of formula (I) are contemplated as well as methods for treating conditions or disorders prevented by or ameliorated by α7 nAChR ligands that encompass compounds of formula (I) and other tricyclic derivatives.
    其中A和B是胺基取代的侧链,Y1和Y2形成各种三环核,Rx是可选的取代基。考虑到公式(I)的化合物和组合物,以及用于治疗由α7 nAChR配体预防或改善的疾病或疾病的方法,这些方法涵盖了公式(I)的化合物和其他三环衍生物。
  • Pharmaceutically useful nitrogen containing heterocyclic derivatives
    申请人:Richardson-Merrell Inc.
    公开号:US03937833A1
    公开(公告)日:1976-02-10
    Bis-basic substituted aromatic polycyclic compounds of the following structure are useful in treating conditions of delayed hypersensitivity: ##SPC1## Wherein [W] represents an aromatic polycyclic nucleus selected from fluoranthene, fluorene, fluoren-9-ol, fluoren-9-one, dibenzofuran, dibenzothiophene, carbazole, N-(lower)alkyl carbazole, xanthene, xanthone, thioxanthene, phenoxathiin, or anthraquinone; Y represents carbonyloxy, carbonylthio, oxygen, divalent sulfur or carbonyl with the provisos that when Y is carbonyloxy or carbonylthio, [W] is other than thioxanthene, phenoxathiin or anthraquinone, when Y is oxygen or divalent sulfur, [W] is other than thioxanthene or phenoxathiin, and when Y is carbonyl, [W] is other than fluoren-9-ol or anthraquinone; A represents a straight or branched alkylene chain of from 1 to 6 carbon atoms with the proviso that when Y is carbonyloxy or carbonylthio, A contains at least 2 straight chain carbon atoms, that is, an ethylene radical; R represents hydrogen, a straight or branched lower alkyl group of from 1 to 4 carbon atoms, phenyl or benzyl; and pharmaceutically useful acid addition salts.
    以下结构的Bis-基取代芳香族多环化合物在治疗延迟型超敏反应方面很有用:##SPC1## 其中[W]代表从荧蒽、芴、芴-9-醇、芴-9-酮、二苯并呋喃、二苯并噻吩、咔唑、N-(较低)烷基咔唑、苯酚氧噻吩或蒽醌中选的芳香族多环核;Y代表羰氧基、羰硫基、氧、二价硫或羰基,但当Y为羰氧基或羰硫基时,[W]不是噻吩、苯酚氧噻吩或蒽醌,当Y为氧或二价硫时,[W]不是噻吩或苯酚氧噻吩,当Y为羰基时,[W]不是芴-9-醇或蒽醌;A代表1至6个碳原子的直链或支链烷基链,但当Y为羰氧基或羰硫基时,A含有至少2个直链碳原子,即乙烯基;R代表氢、1至4个碳原子的直链或支链低级烷基、苯基或苄基;以及药用酸盐。
  • Amino-Substituted Tricyclic Derivatives and Methods of Use
    申请人:Schrimpf Michael R.
    公开号:US20080161281A1
    公开(公告)日:2008-07-03
    Compounds of formula (I) wherein A and B are amine-substituted sidechains, Y 1 and Y 2 form various tricyclic cores, X a and X b are C, CH, or N, as defined herein, and R x is an optional substituent. Compounds and compositions of formula (I) are contemplated as well as methods for treating conditions or disorders prevented by or ameliorated by α7 nAChR ligands that encompass compounds of formula (I) and other tricyclic derivatives. Methods of using amino-substituted tricyclic derivatives also are described herein.
    式(I)的化合物中,A和B是胺基取代的侧链,Y1和Y2形成各种三环核心,Xa和Xb为C、CH或N,如本文所定义,R为可选取代基。本文考虑了式(I)的化合物和组合物,以及用于治疗α7 nAChR配体包括式(I)化合物和其他三环衍生物的条件或障碍的方法。本文还描述了使用氨基取代的三环衍生物的方法。
  • US3937833A
    申请人:——
    公开号:US3937833A
    公开(公告)日:1976-02-10
  • US4041165A
    申请人:——
    公开号:US4041165A
    公开(公告)日:1977-08-09
查看更多